Made possible by the financial support of AbbVie

Study Assesses Brain Volume Differences in Girls with Central Precocious Puberty

An imaging study of girls with idiopathic CPP and matched controls suggests idiopathic CPP was associated with increased gray matter and white matter volumes in the cerebral area.

GnRHa Not Associated with Increased PCOS Risk in Patients with Endocrine Disorders

Using data from more than 50 women, investigators determined exposure to GnRHa treatment was not associated with an increased risk of developing PCOS in women with CPP treated with GnRHa.

Study Details Prevalence of Genetic Variants in Central Precocious Puberty

Results of a recent study provide insight into the prevalence of rare sequence variants among the MKRN3, DLK1, KISS1, and KISS1R genes in children with CPP.

Study Details Factors Negatively Impacting Time to Menarche in Central Precocious Puberty

Mount Sinai-led chart review provides insight into the influence of various factors on time to menarche among girls with central precocious puberty who received GnRHa treatment.

Risk Score Model Could Provide Inexpensive CPP Diagnosis Tool

A cross-sectional study has returned results that suggest a risk score model could help identify patients with central precocious puberty without the need for more expensive and invasive stimulation tests.

Influence of GnRHa on Long-Term Outcomes in Idiopathic Central Precocious Puberty

A systematic review and meta-analysis detail the effects of GnRHa therapy on final adult height, BMI, risk of PCOS, and more long-term outcomes among patients with idiopathic CPP.

Erica Eugster, MD, provides an overview of disease management of central precocious puberty.

Experts from the Mayo Clinic offer insight into the causes, forms, risk factors, and management of precocious puberty.

Experts from the Mayo Clinic offer insight into the causes, forms, risk factors, and management of precocious puberty.

The National Organization for Rare Diseases summarizes available information related to diagnosis and management of precocious puberty as well as providing links to relevant organization and recent journal articles related to precocious puberty.

Experts from Stanford Children’s Health and Lucile Packard Children’s Hospital detail patient-focused data and information for the management of precocious puberty.

Riley Children’s Health provides an overview of key points related to precocious puberty, including links to support services and resources for patients and providers.

AbbVie is pleased to present this program titled “Recognizing the Signs of Central Precocious Puberty (CPP) Earlier: Journey From Patient to Referral Through Case Studies”. This program was originally presented at the annual American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando, Florida. We will be hearing from Karen Oerter Klein, MD who will review the signs of CPP and demonstrate importance of early detection. This presentation will include 3 case studies to reinforce the importance of early diagnosis and referring your patient.

Recognizing Pubertal Onset & Clues on When to Refer for Possible Central Precocious Puberty

Potential Psychosocial Issues Associated with CPP

Clues to Unraveling the Mystery of Central Precocious Puberty

What Is the Pediatrician’s Role?